Advertisement

Journal of Analytical Chemistry

, Volume 72, Issue 11, pp 1184–1192 | Cite as

Application of chromatography–mass spectrometry methods to the control of sport nutrition and medicines marketed via internet

  • A. Z. TemerdashevEmail author
  • A. A. Azaryan
  • A. V. Labutin
  • M. A. Dikunets
  • I. O. Zvereva
  • I. I. Podol’skii
  • G. T. Berodze
  • I. A. Balabaev
Articles

Abstract

Several sport nutrition products and doping drugs sold in the period from 2014 to 2016 were studied using gas and liquid chromatography coupled with mass-spectrometry. In the study, WADA-banned substances were detected in the composition of pre-workout supplements, fat burners, and prohormones. A series of selective androgen receptor modulators and peptide doping drugs were also studied. It was shown that, in some cases, preparations can be adulterated.

Keywords

doping sport nutrition SARM peptide doping ultra-high performance liquid chromatography–tandem mass spectrometry high-resolution mass spectrometry gas chromatography–mass spectrometry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    World Anti-Doping Agency (WADA), The 2017 Prohibited list International Standards. www.wada-ama. org/sites/default/files/resources/files/wada-2016-prohibited-list-en.pdf. Accessed January 8, 2017.Google Scholar
  2. 2.
    Nath, N., Giri, S., Prasad, R., Salem, M.L., Singh, A.K., and Singh, I., J. Immunol., 2005, vol. 175, p. 566.CrossRefGoogle Scholar
  3. 3.
    Baba, M., Ohmura, M., Kishi, N., Okada, Y., Shibata, S., Peng, J., Yao, S., Nishino, H., and Okuyama, T., Biol. Pharm. Bull., 2000, vol. 23 P, p. 660.CrossRefGoogle Scholar
  4. 4.
    Thevis, M., Thomas, A., Fubholler, G., Beuck, S., Geyer, H., and Schanzer, W., Rapid Commun. Mass Spectrom., 2010, vol. 24, p. 2245.CrossRefGoogle Scholar
  5. 5.
    Thevis, M., Thomas, A., and Schanzer, W., Forensic Sci. Int., 2011, vol. 213, p. 35.CrossRefGoogle Scholar
  6. 6.
    Esposito, S., Deventer, K., and Van Eenoo, P., Rapid Commun. Mass Spectrom., 2012, vol. 26, p. 686.CrossRefGoogle Scholar
  7. 7.
    Thevis, M., Thomas, A., Geyer, H., and Schanzer, W., Growth Horm. IGF Res., 2012, vol. 24, p. 276.CrossRefGoogle Scholar
  8. 8.
    Semenistaya, E., Zvereva, I., Krotov, G., and Rodchenkov, G., Drug Test. Anal., 2016, vol. 8, p. 940.CrossRefGoogle Scholar
  9. 9.
    Mazzarino, M., Calvaresi, V., de la Torre, X., Parrotta, G., Sebastianelli, C., and Botre, F., Forensic Toxicol., 2015, vol. 33, p. 321.CrossRefGoogle Scholar
  10. 10.
    Zvereva, I., Semenistaya, E., Krotov, G., and Rodchenkov, G., Analitika, 2014, vol. 3, p. 58.Google Scholar

Copyright information

© Pleiades Publishing, Ltd. 2017

Authors and Affiliations

  • A. Z. Temerdashev
    • 1
    Email author
  • A. A. Azaryan
    • 1
  • A. V. Labutin
    • 2
  • M. A. Dikunets
    • 3
  • I. O. Zvereva
    • 3
  • I. I. Podol’skii
    • 3
  • G. T. Berodze
    • 4
  • I. A. Balabaev
    • 5
  1. 1.Kuban State UniversityKrasnodarRussia
  2. 2.Tomsk Narcological DispensaryTomskRussia
  3. 3.Anti-Doping CenterMoscowRussia
  4. 4.Children’s Regional Clinical HospitalMinistry of Healthcare of the Krasnodar RegionKrasnodarRussia
  5. 5.Chief Administration of the Ministry of Internal Affairs for the Krasnodar RegionKrasnodarRussia

Personalised recommendations